DiagnosTear Technologies Announces Initiation of a Collaboration with LV Prasad Eye Institute for Advancing the Clinical Validation of TeaRx(TM) Red Eye Diagnostic Test
Vancouver, British Columbia–(Newsfile Corp. – November 26, 2025) – DiagnosTear Technologies Inc. (CSE: DTR) (“DiagnosTear” or the “Company”), a leader in developing cutting-edge point-of-care eye diagnostic solutions, is pleased to announce its scientific collaboration with the renowned LV Prasad Eye Institute (LVPEI) in Hyderabad, India. The partnership supports the clinical validation of TeaRx™, the Company’s […]